Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
about
Natural Killer Cells and Liver FibrosisNew insights in hepatocellular carcinoma: from bench to bedsideDiabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsImmunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration.Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in miceTAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapyDeath receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency.Hepatic tissue environment in NEMO-deficient mice critically regulates positive selection of donor cells after hepatocyte transplantationRole of TRAIL and the pro-apoptotic Bcl-2 homolog Bim in acetaminophen-induced liver damage.Differential Cytotoxicity but Augmented IFN-γ Secretion by NK Cells after Interaction with Monocytes from Humans, and Those from Wild Type and Myeloid-Specific COX-2 Knockout Micec-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosisInhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase.Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.TRAIL enhances paracetamol-induced liver sinusoidal endothelial cell death in a Bim- and Bid-dependent mannerLiver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.Innate immune-directed NF-κB signaling requires site-specific NEMO ubiquitination.Role of nuclear factor kappaB in liver health and disease.Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy.Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease.CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.Cell Autonomous and Non-Autonomous Functions of IKKβ and NF-κB during the Pathogenesis of Gastrointestinal Tumors.The concanavalin A model of acute hepatitis in mice.TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model.NK cells: a double-edged sword in chronic hepatitis B virus infection.Development and validation of an intrinsic landmark-based gating protocol applicable for functional and molecular ultrasound imaging.IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis.The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation.The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver.
P2860
Q26767448-29FE4807-AA1A-4258-A2E1-0A0860BF0980Q27026454-4C47FC44-57DB-43AD-89F2-0AB389AA2491Q28386652-A62507F3-4626-4701-80C2-ACF16BEB5E87Q30252731-D61A9BDA-4749-42CC-9C69-382D426D367CQ30495814-86CAE3C4-1D22-4CE6-BAA1-B4DDC1BD0B81Q33523025-12F19887-5C65-43B8-AE64-8DCC6A02C37EQ33615709-37A592DC-424B-4BCE-BBA7-F5EA11619029Q34413462-9871D6F6-19D1-4DB4-B519-468C29E2BC46Q35027678-6AAEF68F-C572-4891-90ED-E353F6CD69E9Q35198534-1F447384-3C85-4068-8BE9-A9AC4BCB9F28Q35202294-A6F671BD-A5B2-49FB-9EF5-6C37276A0D8DQ35701322-B660F9FE-157C-47F5-883D-0DB3D8C81660Q35735269-915154E9-7D58-43D0-AFC7-60169FA3969BQ36044222-758AA35B-0E05-42F4-AC7E-2D1FBE32D304Q36089858-FAA12E6F-6107-4732-8795-06CB117ED5CAQ36525204-D713ED4C-6FD9-4655-8184-88C1322F6703Q37028411-8964F3A3-23A7-4ADB-9F0A-026399E6D0E9Q37350277-BEF20B2E-61DB-4741-92AB-F499EDA4E829Q37720780-C87A708B-901C-4E2D-B70D-26491F82E4EDQ38556534-0350D49B-E279-485D-9AC6-92C0E8D13FE8Q38743167-2BD14047-2D1E-4753-A9AD-1F8689E77D9DQ40282121-99C0DC05-A6A3-4254-AA02-BB97418C1323Q41953684-F8F41402-AC81-40DC-A334-FF4B7E49CDA2Q42150987-B2AF6A4E-4922-444D-9BFF-3771EFE25375Q42259539-2F928040-852C-4C3B-926D-BD26089D5277Q43237496-7C1D1D06-C852-4ECC-B887-196C8FBC4F57Q43553930-85CF366D-0B12-4F6C-BBE3-C11743052AF5Q48163251-62286CBD-3D85-468B-9E3C-68390161BE3AQ50882135-B84C889E-9CE8-4447-9A8A-44A3EFF031B6Q55066176-6042AFBC-BA2B-455F-A6EF-B1C45DC78F9F
P2860
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
@en
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
@nl
type
label
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
@en
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
@nl
prefLabel
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
@en
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
@nl
P2093
P2860
P50
P356
P1476
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
@en
P2093
Christian Trautwein
Julia Freimuth
Leif E Sander
Malika Al-Masaoudi
Yann Malato
P2860
P304
P356
10.1084/JEM.20082152
P407
P577
2009-07-27T00:00:00Z